TrialBMC infectious diseases2016

Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study.

Jiří Beran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.